Cabot (NYSE:CBT) Reaches New 1-Year High – Still a Buy?

Cabot Corporation (NYSE:CBTGet Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $86.54 and last traded at $86.0610, with a volume of 46775 shares changing hands. The stock had previously closed at $86.12.

Wall Street Analyst Weigh In

CBT has been the topic of several research reports. JPMorgan Chase & Co. lifted their price target on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a report on Wednesday, May 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a report on Tuesday. Jefferies Financial Group reaffirmed a “buy” rating and set a $85.00 price target on shares of Cabot in a report on Wednesday, February 4th. UBS Group lifted their price target on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Finally, Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $80.25.

View Our Latest Stock Analysis on Cabot

Cabot Trading Up 1.6%

The firm’s 50-day moving average is $76.83 and its 200 day moving average is $71.89. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $4.52 billion, a price-to-earnings ratio of 16.57, a P/E/G ratio of 11.09 and a beta of 0.78.

Cabot (NYSE:CBTGet Free Report) last posted its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.31 million. During the same period last year, the company earned $1.90 EPS. The firm’s revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities analysts predict that Cabot Corporation will post 6.32 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 29th will be given a dividend of $0.4725 per share. The ex-dividend date is Friday, May 29th. This represents a $1.89 annualized dividend and a yield of 2.2%. This is a boost from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio is 34.03%.

Institutional Investors Weigh In On Cabot

Several hedge funds have recently added to or reduced their stakes in the business. Public Employees Retirement System of Ohio boosted its position in Cabot by 15.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock worth $80,000 after buying an additional 160 shares during the period. Janney Montgomery Scott LLC lifted its position in shares of Cabot by 2.6% in the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock worth $417,000 after purchasing an additional 161 shares during the period. Farther Finance Advisors LLC lifted its position in shares of Cabot by 9.6% in the 4th quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock worth $124,000 after purchasing an additional 164 shares during the period. Parallel Advisors LLC lifted its position in shares of Cabot by 10.5% in the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock worth $139,000 after purchasing an additional 175 shares during the period. Finally, Gabelli Funds LLC lifted its position in shares of Cabot by 1.3% in the 3rd quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock worth $1,032,000 after purchasing an additional 180 shares during the period. 93.18% of the stock is currently owned by institutional investors and hedge funds.

About Cabot

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.